Published in Front Cell Infect Microbiol on April 17, 2012
Characterizing the genetic basis of bacterial phenotypes using genome-wide association studies: a new direction for bacteriology. Genome Med (2014) 0.93
Superantigens subvert the neutrophil response to promote abscess formation and enhance Staphylococcus aureus survival in vivo. Infect Immun (2014) 0.87
Monoclonal antibodies protect from Staphylococcal Enterotoxin K (SEK) induced toxic shock and sepsis by USA300 Staphylococcus aureus. Virulence (2016) 0.86
Superantigens in Staphylococcus aureus isolated from prosthetic joint infection. Diagn Microbiol Infect Dis (2014) 0.85
Emerging functions for the Staphylococcus aureus RNome. PLoS Pathog (2013) 0.84
Dendritic cells during Staphylococcus aureus infection: subsets and roles. J Transl Med (2014) 0.83
CD4+ T cells promote the pathogenesis of Staphylococcus aureus pneumonia. J Infect Dis (2014) 0.83
Superantigens Modulate Bacterial Density during Staphylococcus aureus Nasal Colonization. Toxins (Basel) (2015) 0.82
The staphylococci and staphylococcal pathogenesis. Front Cell Infect Microbiol (2012) 0.82
Detection and measurement of staphylococcal enterotoxin-like K (SEl-K) secretion by Staphylococcus aureus clinical isolates. J Clin Microbiol (2014) 0.81
Topically applied ZnO nanoparticles suppress allergen induced skin inflammation but induce vigorous IgE production in the atopic dermatitis mouse model. Part Fibre Toxicol (2014) 0.81
Antibody-Based Biologics and Their Promise to Combat Staphylococcus aureus Infections. Trends Pharmacol Sci (2015) 0.81
Staphylococcal entertotoxins of the enterotoxin gene cluster (egcSEs) induce nitrous oxide- and cytokine dependent tumor cell apoptosis in a broad panel of human tumor cells. Front Cell Infect Microbiol (2013) 0.80
Levels of alpha-toxin correlate with distinct phenotypic response profiles of blood mononuclear cells and with agr background of community-associated Staphylococcus aureus isolates. PLoS One (2014) 0.79
Staphylococcus aureus-derived factors induce IL-10, IFN-γ and IL-17A-expressing FOXP3(+)CD161(+) T-helper cells in a partly monocyte-dependent manner. Sci Rep (2016) 0.78
Omics Approaches for the Study of Adaptive Immunity to Staphylococcus aureus and the Selection of Vaccine Candidates. Proteomes (2016) 0.77
Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells. Infect Immun (2015) 0.76
Assay of Blood and Synovial Fluid of Patients With Rheumatoid Arthritis for Staphylococcus aureus Enterotoxin D: Absence of Bacteria But Presence of Its Toxin. Jundishapur J Microbiol (2015) 0.75
Positive Feedback Cycle of TNFα Promotes Staphylococcal Enterotoxin B-Induced THP-1 Cell Apoptosis. Front Cell Infect Microbiol (2016) 0.75
The T Cell Response to Staphylococcus aureus. Pathogens (2016) 0.75
Probiotic Lactobacilli Modulate Staphylococcus aureus-Induced Activation of Conventional and Unconventional T cells and NK Cells. Front Immunol (2016) 0.75
Detection of Methicillin Resistance and Various Virulence Factors in Staphylococcus aureus Strains Isolated from Nasal Carriers. Balkan Med J (2015) 0.75
Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients. Ann Lab Med (2014) 0.75
Control of established colon cancer xenografts using a novel humanized single chain antibody-streptococcal superantigen fusion protein targeting the 5T4 oncofetal antigen. PLoS One (2014) 0.75
Detection of Staphylococcus Enterotoxin B (SEB) Using an Immunochromatographic Test Strip. Jundishapur J Microbiol (2015) 0.75
Staphylococcal enterotoxin H induced apoptosis of bovine mammary epithelial cells in vitro. Toxins (Basel) (2014) 0.75
Staphylococcal enterotoxin-like X (SElX) is a unique superantigen with functional features of two major families of staphylococcal virulence factors. PLoS Pathog (2017) 0.75
A potential role for staphylococcal and streptococcal superantigens in driving skewing of TCR Vβ subsets in tonsillar hyperplasia. Med Microbiol Immunol (2017) 0.75
Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group. N Engl J Med (2001) 14.84
The staphylococcal enterotoxins and their relatives. Science (1990) 11.99
Toxic-shock syndrome associated with phage-group-I Staphylococci. Lancet (1978) 10.25
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol Gen Genet (1986) 9.54
Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic-shock syndrome. J Infect Dis (1981) 8.40
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 8.01
Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcus aureus and clinical features in 52 cases. N Engl J Med (1980) 7.85
A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet (1981) 7.69
Interaction of Staphylococcus aureus toxin "superantigens" with human T cells. Proc Natl Acad Sci U S A (1989) 7.48
T cell activation. Annu Rev Immunol (2009) 7.40
Crystal structure of a T-cell receptor beta-chain complexed with a superantigen. Nature (1996) 7.11
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol (1990) 3.89
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature (1994) 3.60
An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat Med (2002) 3.39
Staphylococcal enterotoxin B and toxic-shock syndrome toxin-1 are significantly associated with non-menstrual TSS. Lancet (1986) 2.69
In vivo induction of anergy in peripheral V beta 8+ T cells by staphylococcal enterotoxin B. J Exp Med (1990) 2.69
Selective expansion of T cells expressing T-cell receptor variable regions V beta 2 and V beta 8 in Kawasaki disease. Proc Natl Acad Sci U S A (1992) 2.56
Selective anergy of V beta 8+,CD4+ T cells in Staphylococcus enterotoxin B-primed mice. J Exp Med (1990) 2.47
Structural basis of T cell recognition. Annu Rev Immunol (1999) 2.45
Bacterial superantigens. Clin Exp Immunol (2003) 2.42
The structural basis of T cell activation by superantigens. Annu Rev Immunol (1999) 2.34
The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med (2008) 2.25
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. Science (1994) 2.24
Identification and characterization of staphylococcal enterotoxin types G and I from Staphylococcus aureus. Infect Immun (1998) 2.22
Understanding how leading bacterial pathogens subvert innate immunity to reveal novel therapeutic targets. J Allergy Clin Immunol (2007) 2.19
Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma. J Allergy Clin Immunol (2010) 2.19
Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J Clin Microbiol (2007) 2.17
A rabbit model of toxic shock syndrome that uses a constant, subcutaneous infusion of toxic shock syndrome toxin 1. Infect Immun (1987) 2.13
Prevalence of serum antibody to staphylococcal enterotoxin F among Wisconsin residents: implications for toxic-shock syndrome. J Infect Dis (1983) 2.08
Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J (2000) 2.00
Binding of superantigen toxins into the CD28 homodimer interface is essential for induction of cytokine genes that mediate lethal shock. PLoS Biol (2011) 1.93
Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J Clin Invest (1993) 1.87
Pathogenesis of chronic rhinosinusitis: inflammation. J Allergy Clin Immunol (2011) 1.86
Food poisoning and Staphylococcus aureus enterotoxins. Toxins (Basel) (2010) 1.84
Standard nomenclature for the superantigens expressed by Staphylococcus. J Infect Dis (2004) 1.78
Superantigens: microbial agents that corrupt immunity. Lancet Infect Dis (2002) 1.76
Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol Rev (2011) 1.71
Three-dimensional structure of the complex between a T cell receptor beta chain and the superantigen staphylococcal enterotoxin B. Immunity (1998) 1.68
Bacterial superantigens induce T cell expression of the skin-selective homing receptor, the cutaneous lymphocyte-associated antigen, via stimulation of interleukin 12 production. J Exp Med (1995) 1.65
Anti-staphylococcal humoral immune response in persistent nasal carriers and noncarriers of Staphylococcus aureus. J Infect Dis (2009) 1.62
Early diagnosis and treatment of toxic shock syndrome in paediatric burns. Burns (2005) 1.59
Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II. J Exp Med (1995) 1.58
How the T cell receptor sees antigen--a structural view. Cell (2005) 1.58
Characterization of two distinct MHC class II binding sites in the superantigen staphylococcal enterotoxin A. EMBO J (1995) 1.54
Comparative prevalence of superantigen genes in Staphylococcus aureus isolates causing sepsis with and without septic shock. Clin Infect Dis (2005) 1.53
Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists. Nat Med (2007) 1.52
A flow cytometric method to estimate the precursor frequencies of cells proliferating in response to specific antigens. J Immunol Methods (1999) 1.46
In vivo responses of CD4+ and CD8+ cells to bacterial superantigens. Eur J Immunol (1992) 1.45
Staphylococcal toxic shock syndrome 2000-2006: epidemiology, clinical features, and molecular characteristics. PLoS One (2011) 1.43
Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol (2004) 1.43
Crystal structure of a superantigen bound to the high-affinity, zinc-dependent site on MHC class II. Immunity (2001) 1.42
Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. J Allergy Clin Immunol (2010) 1.42
Active surveillance for toxic shock syndrome in the United States, 1986. Rev Infect Dis (1989) 1.41
egc-Encoded superantigens from Staphylococcus aureus are neutralized by human sera much less efficiently than are classical staphylococcal enterotoxins or toxic shock syndrome toxin. Infect Immun (2004) 1.41
A novel core genome-encoded superantigen contributes to lethality of community-associated MRSA necrotizing pneumonia. PLoS Pathog (2011) 1.37
Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York. Appl Environ Microbiol (2009) 1.32
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
Genetic control of susceptibility to group A streptococcal infection in mice. J Infect Dis (2001) 1.31
Superantigen-induced T cell:B cell conjugation is mediated by LFA-1 and requires signaling through Lck, but not ZAP-70. J Immunol (2001) 1.30
Temporal expression of adhesion factors and activity of global regulators during establishment of Staphylococcus aureus nasal colonization. J Infect Dis (2010) 1.30
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med (2009) 1.29
Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci U S A (2006) 1.26
Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity (2006) 1.26
Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 1.25
Anergy and cytokine-mediated suppression as distinct superantigen-induced tolerance mechanisms in vivo. J Exp Med (1999) 1.24
Development of serum antibody to toxic shock toxin among individuals with toxic shock syndrome in Wisconsin. J Infect Dis (1985) 1.23
Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1. Mol Microbiol (1994) 1.22
Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. Clin Infect Dis (2008) 1.22
Staphylococcus aureus carriers neutralize superantigens by antibodies specific for their colonizing strain: a potential explanation for their improved prognosis in severe sepsis. J Infect Dis (2006) 1.21
Crystal structure of a superantigen bound to MHC class II displays zinc and peptide dependence. EMBO J (2001) 1.21
Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome. Clin Infect Dis (2004) 1.18
Pyrogenic toxin superantigen site specificity in toxic shock syndrome and food poisoning in animals. Infect Immun (2000) 1.18
Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol (2010) 1.17
High prevalence of Staphylococcus aureus cultivation and superantigen production in patients with psoriasis. Eur J Dermatol (2009) 1.17
Humanlike immune response of human leukocyte antigen-DR3 transgenic mice to staphylococcal enterotoxins: a novel model for superantigen vaccines. J Infect Dis (2002) 1.17
Hemoglobin promotes Staphylococcus aureus nasal colonization. PLoS Pathog (2011) 1.17
Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype. J Immunol (2010) 1.15
Comparative analysis of lipopolysaccharide-induced tumor necrosis factor alpha activity in serum and lethality in mice and rabbits pretreated with the staphylococcal superantigen toxic shock syndrome toxin 1. Infect Immun (2001) 1.14
Toxic-shock syndrome in Minnesota: results of an active-passive surveillance system. J Infect Dis (1982) 1.14
Structural basis for evasion of IgA immunity by Staphylococcus aureus revealed in the complex of SSL7 with Fc of human IgA1. Proc Natl Acad Sci U S A (2007) 1.13
Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock. Eur J Immunol (1996) 1.12
Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. J Clin Invest (1995) 1.10
Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. J Allergy Clin Immunol (1999) 1.09
The crystal structure of staphylococcal superantigen-like protein 11 in complex with sialyl Lewis X reveals the mechanism for cell binding and immune inhibition. Mol Microbiol (2007) 1.07
Staphylococcus aureus superantigens elicit redundant and extensive human Vbeta patterns. Infect Immun (2009) 1.06
Staphylococcal enterotoxin H induces V alpha-specific expansion of T cells. J Immunol (2003) 1.05
Polyclonal expansion of TCRBV2- and TCRBV6-bearing T cells in patients with Kawasaki disease. Immunology (1999) 1.04
The role of superantigens of group A Streptococcus and Staphylococcus aureus in Kawasaki disease. Curr Opin Infect Dis (2007) 1.04
Major histocompatibility complex class II-associated peptides control the presentation of bacterial superantigens to T cells. J Exp Med (1996) 1.04
Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J (2007) 1.03
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J Allergy Clin Immunol (2000) 1.03
Activation of MyD88 signaling upon staphylococcal enterotoxin binding to MHC class II molecules. PLoS One (2011) 1.02
Crystal structures of the staphylococcal toxin SSL5 in complex with sialyl Lewis X reveal a conserved binding site that shares common features with viral and bacterial sialic acid binding proteins. J Mol Biol (2007) 1.02
Analysis of superantigenic toxin Vbeta T-cell signatures produced during cases of staphylococcal toxic shock syndrome and septic shock. Clin Microbiol Infect (2008) 1.01
Kawasaki-like syndromes in HIV-infected adults. J Infect (2007) 1.01
Immune evasion cluster-positive bacteriophages are highly prevalent among human Staphylococcus aureus strains, but they are not essential in the first stages of nasal colonization. Clin Microbiol Infect (2011) 1.00
Genome sequence of a serotype M3 strain of group A Streptococcus: phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc Natl Acad Sci U S A (2002) 5.07
Potential uses of probiotics in clinical practice. Clin Microbiol Rev (2003) 2.80
Characterization and expression analysis of Staphylococcus aureus pathogenicity island 3. Implications for the evolution of staphylococcal pathogenicity islands. J Biol Chem (2002) 1.88
Repression of the Staphylococcus aureus accessory gene regulator in serum and in vivo. J Bacteriol (2002) 1.73
Structures of two streptococcal superantigens bound to TCR beta chains reveal diversity in the architecture of T cell signaling complexes. Structure (2002) 1.31
Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome. Nat Med (2009) 1.29
Long-range cooperative binding effects in a T cell receptor variable domain. Proc Natl Acad Sci U S A (2006) 1.26
Bacterial superantigens bypass Lck-dependent T cell receptor signaling by activating a Galpha11-dependent, PLC-beta-mediated pathway. Immunity (2006) 1.26
An amino-terminal domain of Enterococcus faecalis aggregation substance is required for aggregation, bacterial internalization by epithelial cells and binding to lipoteichoic acid. Mol Microbiol (2004) 1.14
Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc Natl Acad Sci U S A (2011) 1.11
Antihomocitrullinated fibrinogen antibodies are specific to rheumatoid arthritis and frequently bind citrullinated proteins/peptides. J Rheumatol (2014) 1.07
Structural basis of T-cell specificity and activation by the bacterial superantigen TSST-1. EMBO J (2007) 1.03
A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes (2014) 1.03
Crystal structure of the streptococcal superantigen SpeI and functional role of a novel loop domain in T cell activation by group V superantigens. J Mol Biol (2007) 1.01
Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOF-MS): a new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal (2004) 0.97
Characterization of two novel pyrogenic toxin superantigens made by an acute rheumatic fever clone of Streptococcus pyogenes associated with multiple disease outbreaks. Infect Immun (2002) 0.94
CD1d-independent activation of mouse and human iNKT cells by bacterial superantigens. Immunol Cell Biol (2011) 0.94
Inhibition of expression of a staphylococcal superantigen-like protein by a soluble factor from Lactobacillus reuteri. Microbiology (2006) 0.93
Molecular basis of TCR selectivity, cross-reactivity, and allelic discrimination by a bacterial superantigen: integrative functional and energetic mapping of the SpeC-Vbeta2.1 molecular interface. J Immunol (2006) 0.91
A novel loop domain in superantigens extends their T cell receptor recognition site. J Mol Biol (2007) 0.91
Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats. J Infect Dis (2008) 0.87
Influence of the vaginal microbiota on toxic shock syndrome toxin 1 production by Staphylococcus aureus. Appl Environ Microbiol (2013) 0.85
The zinc-dependent major histocompatibility complex class II binding site of streptococcal pyrogenic exotoxin C is critical for maximal superantigen function and toxic activity. Infect Immun (2003) 0.83
T cell signalling induced by bacterial superantigens. Chem Immunol Allergy (2007) 0.83
The T cell receptor beta-chain second complementarity determining region loop (CDR2beta governs T cell activation and Vbeta specificity by bacterial superantigens. J Biol Chem (2010) 0.83
Effects of total body irradiation and cyclosporin a on the lethality of toxic shock syndrome toxin-1 in a rabbit model of toxic shock syndrome. J Infect Dis (2003) 0.82
Molecular requirements for MHC class II alpha-chain engagement and allelic discrimination by the bacterial superantigen streptococcal pyrogenic exotoxin C. J Immunol (2008) 0.79
Fournier's gangrene of the penis caused by Streptococcus dysgalactiae subspecies equisimilis: case report and incidence study in a tertiary-care hospital. BMC Infect Dis (2013) 0.75
Time for probiotics. Lancet Infect Dis (2002) 0.75